Naser Nabil, Dzubur Alen, Durak Azra, Kulic Mehmed, Naser Nura
Polyclinic "Dr. Nabil", Sarajevo, Bosnia and Herzegovina.
Institute for heart diseases, University Clinical Center Sarajevo, Bosnia and Herzegovina.
Med Arch. 2016 Jul 27;70(4):274-279. doi: 10.5455/medarh.2016.70.274-279.
The term masked hypertension (MH) should be used for untreated individuals who have normal office blood pressure but elevated ambulatory blood pressure. For treated patients, this condition should be termed masked uncontrolled hypertension (MUCH).
Masked uncontrolled hypertension (MUCH) has gone unrecognized because few studies have used 24-h ABPM to determine the prevalence of suboptimal BP control in seemingly well-treated patients, and there are few such studies in large cohorts of treated patients attending usual clinical practice. This is important because masked hypertension is associated with a high risk of cardiovascular events. This study was conducted to obtain more information about the association between hypertension and other CV risk factors, about office and ambulatory blood pressure (BP) control as well as on cardiovascular (CV) risk profile in treated hypertensive patients, also to define the prevalence and characteristics of masked uncontrolled hypertension (MUCH) among treated hypertensive patients in routine clinical practice.
In this study 2514 male and female patients were included during a period of 5 years follow up. All patients have ambulatory blood pressure monitoring (ABPM) for at least 24h. We identified patients with treated and controlled BP according to current international guidelines (clinic BP, 140/90mmHg). Cardiovascular risk assessment was based on personal history, clinic BP values, as well as target organ damage evaluation. Masked uncontrolled hypertension (MUCH) was diagnosed in these patients if despite controlled clinic BP, the mean 24-h ABPM average remained elevated (24-h systolic BP ≥130mmHg and/or 24-h diastolic BP ≥80mmHg).
Patients had a mean age of 60.2+10 years, and the majority of them (94.6%) were followed by specialist physicians. Average clinic BP was 150.4+16/89.9+12 mmHg. About 70% of patients displayed a very high-risk profile. Ambulatory blood pressure monitoring (ABPM) was performed in all recruited patients for at least 24h. Despite the combined medical treatment (78% of the patients), clinic control (<140/90 mmHg) was achieved in only 26.2% of patients, the corresponding control rate for ambulatory BP (<130/80 mmHg) being 32.7%. From 2514 patients with treated BP, we identified 803 with treated and controlled office BP control (<140/90 mmHg), of whom 258 patients (32.1%) had MUCH according to 24-h ABPM criteria (mean age 57.2 years, 54.7% men). The prevalence of MUCH was slightly higher in males, patients with borderline clinic and office BP (130-139/80-89 mmHg), and patients at high cardiovascular risk (smokers, diabetes, obesity). Masked uncontrolled hypertension (MUCH) was most often due to poor control of nocturnal BP, with the proportion of patients in whom MUCH was solely attributable to an elevated nocturnal BP almost double that solely attributable to daytime BP elevation (22.3 vs. 10.1%, P 0.001).
The prevalence of masked suboptimal BP control in patients with treated and well-controlled clinic BP is high. The characteristics of patients with MUCH (male, longer duration of hypertension, obesity, smoking history, and diabetes) indicate that this is a higher-risk group with most to gain from improved BP.
术语“隐匿性高血压(MH)”应用于诊室血压正常但动态血压升高的未治疗个体。对于已治疗患者,这种情况应称为隐匿性未控制高血压(MUCH)。
隐匿性未控制高血压(MUCH)一直未被认识到,因为很少有研究使用24小时动态血压监测(ABPM)来确定看似治疗良好的患者中血压控制未达最佳水平的患病率,并且在接受常规临床治疗的大量已治疗患者队列中此类研究很少。这很重要,因为隐匿性高血压与心血管事件的高风险相关。本研究旨在获取更多关于高血压与其他心血管风险因素之间的关联、诊室和动态血压(BP)控制以及已治疗高血压患者的心血管(CV)风险概况的信息,同时确定常规临床实践中已治疗高血压患者中隐匿性未控制高血压(MUCH)的患病率和特征。
本研究纳入了2514名男性和女性患者,进行了为期5年的随访。所有患者均进行了至少24小时的动态血压监测(ABPM)。我们根据当前国际指南(诊室血压,140/90mmHg)确定已治疗且血压得到控制的患者。心血管风险评估基于个人病史、诊室血压值以及靶器官损害评估。如果这些患者尽管诊室血压得到控制,但24小时ABPM平均值仍升高(24小时收缩压≥130mmHg和/或24小时舒张压≥80mmHg),则诊断为隐匿性未控制高血压(MUCH)。
患者的平均年龄为60.2±10岁,他们中的大多数(94.6%)由专科医生随访。平均诊室血压为150.4±16/89.9±12mmHg。约70%的患者表现出极高的风险概况。所有招募的患者均进行了至少24小时的动态血压监测(ABPM)。尽管联合药物治疗(78%的患者),但仅26.2%的患者实现了诊室血压控制(<140/90mmHg),动态血压相应的控制率(<130/80mmHg)为32.7%。在2514例已治疗血压的患者中,我们确定了803例诊室血压已治疗且得到控制(<140/90mmHg)的患者,其中258例患者(32.1%)根据24小时ABPM标准患有MUCH(平均年龄57.2岁,54.7%为男性)。MUCH在男性、诊室和家庭血压临界值(130 - 139/80 - 89mmHg)的患者以及心血管风险高的患者(吸烟者、糖尿病患者、肥胖者)中患病率略高。隐匿性未控制高血压(MUCH)最常见的原因是夜间血压控制不佳,MUCH仅归因于夜间血压升高的患者比例几乎是仅归因于白天血压升高患者比例的两倍(22.3%对10.1%,P<0.001)。
在已治疗且诊室血压控制良好的患者中,隐匿性血压控制未达最佳水平的患病率很高。MUCH患者的特征(男性、高血压病程较长、肥胖、吸烟史和糖尿病)表明这是一个从改善血压中获益最大的高风险群体。